Dernières publications scientifiques

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) Derisbourg Sara
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) Goffard Jean-Christophe
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) BOULVAIN MICHEL
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Bucalau Ana-Maria
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Navez Julie
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Loi Patrizia
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Pezzullo Martina
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Van Laethem Jean-Luc
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Mans Laura
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola